<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02819011</url>
  </required_header>
  <id_info>
    <org_study_id>H-38050</org_study_id>
    <nct_id>NCT02819011</nct_id>
  </id_info>
  <brief_title>OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO</brief_title>
  <official_title>OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bijan Najafi, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Orthotic Holdings, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a randomized control trial to evaluate long term effects and
      effectiveness of Moore Balance Brace (MBB) ankle foot orthoses (AFO) in reducing risk of
      falling in older adults.

      Primary Endpoints • Characterize the impact of MBB AFO on balance, gait, risk of falling,
      frailty status, and adverse events

      Secondary Endpoints • Characterize the Impact of MBB AFO on spontaneous daily physical
      activities • Characterize the feasibility of the MBB AFO device on patient adherence,
      acceptability, user-friendliness, and perception of benefit for daily usage
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">April 4, 2019</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hip Sway Change From Baseline to 6 Months</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ankle Sway Change From Baseline to 6 Months</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>Ankle sway (motion of ankle joint in three dimensions) measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Center of Mass (COM) Sway Change Baseline to 6 Months</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>Center of Mass (COM) sway measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence (Hours Per Day to Wear Ankle-Foot Orthosis (AFO))</measure>
    <time_frame>6 months</time_frame>
    <description>The adherence of participants to the prescribed Ankle-Foot Orthosis (AFO) plus walking shoes was quantified using the response to a self-reported question (&quot;How many hours per day did you wear the prescribed footwear?&quot;).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fall Incidents</measure>
    <time_frame>Baseline, 12 months</time_frame>
    <description>Fall incidents during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concern for Falling Change Form Baseline to 6 Months</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Concern for falling is quantified by Falls Efficacy Scale - International (FES-I) questionnaire. Scores range from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling). Higher score indicate worse performance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Level</measure>
    <time_frame>baseline to 6 months</time_frame>
    <description>Physical activity level for 24 hours while wearing their own shoes compared to the walking shoes and compared to walking shoes plus Ankle-Foot Orthosis (AFO). To quantify physical activity, number of taken steps per day was monitored using a pendant wearable sensor called, PAMSys (Biosensics, MA, USA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Adverse Events</measure>
    <time_frame>assessed at 1, 3, 6, and 12 months, month 12 reported</time_frame>
    <description>Number of participants with adverse events reported during the study. Adverse events was inquired at 1 months, 3 months, 6 months, 12 months after the baseline, and summed at 12 months. If the participant has at least one adverse event reported in any assessed time frame, the participant will be categorized as the participant with adverse event.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Found the Device Useful and Easy to Use</measure>
    <time_frame>6 months</time_frame>
    <description>The participants perceived usefulness of ease of use of wearing Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) based on questionnaires of A technology acceptance model (TAM). Perceived usefulness was assessed using two questions (i.e., &quot;I feel more stable when standing,&quot; and &quot;I feel more stable when walking&quot;). Perceived ease of use was assessed using two questions (i.e., &quot;Was easy to take on and off,&quot; and &quot;Was comfortable to wear&quot;). The Likert scale (6-point scale from 0-5) was used to quantify how much they disagreed with each statement, including &quot;strongly disagree,&quot; &quot;disagree,&quot; &quot;somewhat disagree,&quot; &quot;somewhat agree,&quot; &quot;agree,&quot; and &quot;strongly agree,&quot; respectively. In this paper, responses were only categorized as positive (3-5 points) or negative (0-2 points) attitudes towards the use of AFO plus walking shoes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stride Velocity</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>stride velocity measured in single-task walking with normal speed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stride Time</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>stride time measured in single task walking with normal speed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stride Length</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>stride length measured in single-task walking with normal speed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Accidental Falls</condition>
  <condition>Fall Due to Loss of Equilibrium</condition>
  <condition>High Risk of Falls Due to Mobility Limitation</condition>
  <condition>Diabetes</condition>
  <condition>Arthritis</condition>
  <condition>Cancer</condition>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Parkinson's Disease</condition>
  <condition>End Stage Renal Failure on Dialysis</condition>
  <arm_group>
    <arm_group_label>MBB AFO Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made MBB AFO for the duration of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No MBB AFO Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MBB AFO</intervention_name>
    <description>Subjects will be provided with a pair of New Balance 813 shoes plus a custom made MBB AFO</description>
    <arm_group_label>MBB AFO Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Subjects will be provided with a pair of New Balance 813 shoes</description>
    <arm_group_label>No MBB AFO Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 65 or older

          -  High concerns or high risk of fall

          -  Ambulatory

        Exclusion Criteria:

          -  Presence of an active wound infection on either of the foot and ankle

          -  Use of medication or a medical condition that may have unstable (fluctuate over time)
             or temporary (less than one month) impact on gait and balance

          -  Acute fractures on the foot

          -  Participant of an interventional study within the last 30 days

          -  Non-ambulatory or unable to stand without help or walk a distance of at least 1.8 m
             (~six feet) without assistance

          -  Major foot amputation

          -  Unable or unwilling to participate in all procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Wang C, Goel R, Rahemi H, Zhang Q, Lepow B, Najafi B. Effectiveness of Daily Use of Bilateral Custom-Made Ankle-Foot Orthoses on Balance, Fear of Falling, and Physical Activity in Older Adults: A Randomized Controlled Trial. Gerontology. 2019;65(3):299-307. doi: 10.1159/000494114. Epub 2018 Nov 30.</citation>
    <PMID>30504728</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang C, Goel R, Zhang Q, Lepow B, Najafi B. Daily Use of Bilateral Custom-Made Ankle-Foot Orthoses for Fall Prevention in Older Adults: A Randomized Controlled Trial. J Am Geriatr Soc. 2019 Aug;67(8):1656-1661. doi: 10.1111/jgs.15929. Epub 2019 Apr 24.</citation>
    <PMID>31018018</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 28, 2016</study_first_submitted>
  <study_first_submitted_qc>June 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2016</study_first_posted>
  <results_first_submitted>January 16, 2020</results_first_submitted>
  <results_first_submitted_qc>February 26, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 27, 2020</results_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Bijan Najafi, PhD</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>Ankle Foot Orthoses</keyword>
  <keyword>falls</keyword>
  <keyword>Fall Prevention</keyword>
  <keyword>Frailty</keyword>
  <keyword>Concern for falls</keyword>
  <keyword>Footwear</keyword>
  <keyword>Mobility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Mobility Limitation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Only de-identified data and associated results will be published in peer-reviewed papers or scientific abstracts</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 16, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT02819011/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 2, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT02819011/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
          <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
        </group>
        <group group_id="P2">
          <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
          <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
          <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
        </group>
        <group group_id="B2">
          <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
          <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.7" spread="6.3"/>
                    <measurement group_id="B2" value="75.6" spread="6.5"/>
                    <measurement group_id="B3" value="74.7" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hip Sway Change From Baseline to 6 Months</title>
        <description>Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
        <time_frame>baseline to 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Hip Sway Change From Baseline to 6 Months</title>
          <description>Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>degree^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.65" spread="3.22"/>
                    <measurement group_id="O2" value="3.75" spread="3.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>@6Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.15" spread="1.24"/>
                    <measurement group_id="O2" value="3.89" spread="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare changes in two groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.040</p_value>
            <p_value_desc>priori threshold for statistical significance= 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ankle Sway Change From Baseline to 6 Months</title>
        <description>Ankle sway (motion of ankle joint in three dimensions) measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
        <time_frame>baseline to 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Ankle Sway Change From Baseline to 6 Months</title>
          <description>Ankle sway (motion of ankle joint in three dimensions) measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>degree^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.50" spread="3.74"/>
                    <measurement group_id="O2" value="3.21" spread="2.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>@6Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="0.69"/>
                    <measurement group_id="O2" value="3.56" spread="2.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes in both groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>a priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Center of Mass (COM) Sway Change Baseline to 6 Months</title>
        <description>Center of Mass (COM) sway measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
        <time_frame>baseline to 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Center of Mass (COM) Sway Change Baseline to 6 Months</title>
          <description>Center of Mass (COM) sway measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.50"/>
                    <measurement group_id="O2" value="0.85" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>@6Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.32" spread="0.18"/>
                    <measurement group_id="O2" value="0.76" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes in both groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.019</p_value>
            <p_value_desc>a priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adherence (Hours Per Day to Wear Ankle-Foot Orthosis (AFO))</title>
        <description>The adherence of participants to the prescribed Ankle-Foot Orthosis (AFO) plus walking shoes was quantified using the response to a self-reported question (&quot;How many hours per day did you wear the prescribed footwear?&quot;).</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Adherence (Hours Per Day to Wear Ankle-Foot Orthosis (AFO))</title>
          <description>The adherence of participants to the prescribed Ankle-Foot Orthosis (AFO) plus walking shoes was quantified using the response to a self-reported question (&quot;How many hours per day did you wear the prescribed footwear?&quot;).</description>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" spread="3.3"/>
                    <measurement group_id="O2" value="5.6" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fall Incidents</title>
        <description>Fall incidents during the study</description>
        <time_frame>Baseline, 12 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 and 12 months. Generalized Estimating Equation Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Fall Incidents</title>
          <description>Fall incidents during the study</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 and 12 months. Generalized Estimating Equation Analysis can handle such missing data</population>
          <units>falls per year precedent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.27" spread="4.17"/>
                    <measurement group_id="O2" value="1.82" spread="4.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>@12Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.80" spread="1.27"/>
                    <measurement group_id="O2" value="0.94" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes of both groups from pre-intervention to post-intervention year.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.572</p_value>
            <p_value_desc>priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Generalized Estimating Equations</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Concern for Falling Change Form Baseline to 6 Months</title>
        <description>Concern for falling is quantified by Falls Efficacy Scale - International (FES-I) questionnaire. Scores range from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling). Higher score indicate worse performance.</description>
        <time_frame>Baseline, 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) : Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Concern for Falling Change Form Baseline to 6 Months</title>
          <description>Concern for falling is quantified by Falls Efficacy Scale - International (FES-I) questionnaire. Scores range from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling). Higher score indicate worse performance.</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.8" spread="10.7"/>
                    <measurement group_id="O2" value="33.3" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>@6Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.0" spread="9.0"/>
                    <measurement group_id="O2" value="30.1" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes between groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.650</p_value>
            <p_value_desc>a priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physical Activity Level</title>
        <description>Physical activity level for 24 hours while wearing their own shoes compared to the walking shoes and compared to walking shoes plus Ankle-Foot Orthosis (AFO). To quantify physical activity, number of taken steps per day was monitored using a pendant wearable sensor called, PAMSys (Biosensics, MA, USA).</description>
        <time_frame>baseline to 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Physical Activity Level</title>
          <description>Physical activity level for 24 hours while wearing their own shoes compared to the walking shoes and compared to walking shoes plus Ankle-Foot Orthosis (AFO). To quantify physical activity, number of taken steps per day was monitored using a pendant wearable sensor called, PAMSys (Biosensics, MA, USA).</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>number of steps per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4017" spread="2008"/>
                    <measurement group_id="O2" value="3847" spread="3645"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>@6Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4872" spread="2657"/>
                    <measurement group_id="O2" value="4297" spread="2735"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes between groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.756</p_value>
            <p_value_desc>a priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Adverse Events</title>
        <description>Number of participants with adverse events reported during the study. Adverse events was inquired at 1 months, 3 months, 6 months, 12 months after the baseline, and summed at 12 months. If the participant has at least one adverse event reported in any assessed time frame, the participant will be categorized as the participant with adverse event.</description>
        <time_frame>assessed at 1, 3, 6, and 12 months, month 12 reported</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Events</title>
          <description>Number of participants with adverse events reported during the study. Adverse events was inquired at 1 months, 3 months, 6 months, 12 months after the baseline, and summed at 12 months. If the participant has at least one adverse event reported in any assessed time frame, the participant will be categorized as the participant with adverse event.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Found the Device Useful and Easy to Use</title>
        <description>The participants perceived usefulness of ease of use of wearing Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) based on questionnaires of A technology acceptance model (TAM). Perceived usefulness was assessed using two questions (i.e., &quot;I feel more stable when standing,&quot; and &quot;I feel more stable when walking&quot;). Perceived ease of use was assessed using two questions (i.e., &quot;Was easy to take on and off,&quot; and &quot;Was comfortable to wear&quot;). The Likert scale (6-point scale from 0-5) was used to quantify how much they disagreed with each statement, including &quot;strongly disagree,&quot; &quot;disagree,&quot; &quot;somewhat disagree,&quot; &quot;somewhat agree,&quot; &quot;agree,&quot; and &quot;strongly agree,&quot; respectively. In this paper, responses were only categorized as positive (3-5 points) or negative (0-2 points) attitudes towards the use of AFO plus walking shoes.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Found the Device Useful and Easy to Use</title>
          <description>The participants perceived usefulness of ease of use of wearing Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) based on questionnaires of A technology acceptance model (TAM). Perceived usefulness was assessed using two questions (i.e., &quot;I feel more stable when standing,&quot; and &quot;I feel more stable when walking&quot;). Perceived ease of use was assessed using two questions (i.e., &quot;Was easy to take on and off,&quot; and &quot;Was comfortable to wear&quot;). The Likert scale (6-point scale from 0-5) was used to quantify how much they disagreed with each statement, including &quot;strongly disagree,&quot; &quot;disagree,&quot; &quot;somewhat disagree,&quot; &quot;somewhat agree,&quot; &quot;agree,&quot; and &quot;strongly agree,&quot; respectively. In this paper, responses were only categorized as positive (3-5 points) or negative (0-2 points) attitudes towards the use of AFO plus walking shoes.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>perceived usefulness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>perceived ease of use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stride Velocity</title>
        <description>stride velocity measured in single-task walking with normal speed</description>
        <time_frame>baseline, 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Stride Velocity</title>
          <description>stride velocity measured in single-task walking with normal speed</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>m/sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.80" spread="0.23"/>
                    <measurement group_id="O2" value="0.81" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.27"/>
                    <measurement group_id="O2" value="0.88" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes between groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.769</p_value>
            <p_value_desc>a priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stride Time</title>
        <description>stride time measured in single task walking with normal speed</description>
        <time_frame>baseline, 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Stride Time</title>
          <description>stride time measured in single task walking with normal speed</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.27" spread="0.18"/>
                    <measurement group_id="O2" value="1.24" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.25" spread="0.23"/>
                    <measurement group_id="O2" value="1.21" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes between groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.857</p_value>
            <p_value_desc>a priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stride Length</title>
        <description>stride length measured in single-task walking with normal speed</description>
        <time_frame>baseline, 6 months</time_frame>
        <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
        <group_list>
          <group group_id="O1">
            <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
          </group>
          <group group_id="O2">
            <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
            <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
          </group>
        </group_list>
        <measure>
          <title>Stride Length</title>
          <description>stride length measured in single-task walking with normal speed</description>
          <population>Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data</population>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.98" spread="0.17"/>
                    <measurement group_id="O2" value="0.96" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.22"/>
                    <measurement group_id="O2" value="1.01" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Repeated measures to compare the changes between groups from baseline to 6 months</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.829</p_value>
            <p_value_desc>a priori threshold for statistical significance = 0.05</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Incident of falls related to footwear/AFO, pain, and other relevant adverse events such as callus, foot ulcers, etc</desc>
      <group_list>
        <group group_id="E1">
          <title>Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
          <description>This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)</description>
        </group>
        <group group_id="E2">
          <title>No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group</title>
          <description>This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof.Bijan Najafi</name_or_title>
      <organization>Baylor College of Medicine</organization>
      <phone>17137987536</phone>
      <email>bijan.najafi@bcm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

